Q1 2023 13F Holders as of 31 Mar 2023
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
88,862,154
-
Share change
-
+23,602,379
-
Total reported value
-
$774,919,455
-
Put/Call ratio
-
69%
-
Price per share
-
$8.72
-
Number of holders
-
138
-
Value change
-
+$217,014,250
-
Number of buys
-
83
-
Number of sells
-
55
Institutional Holders of CYMABAY THERAPEUTICS INC - COM (CBAY) as of Q1 2023
As of 31 Mar 2023,
CYMABAY THERAPEUTICS INC - COM (CBAY) was held by
138 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
88,862,154 shares.
The largest 10 holders included
Avoro Capital Advisors LLC, JANUS HENDERSON GROUP PLC, Octagon Capital Advisors LP, VANGUARD GROUP INC, ADAGE CAPITAL PARTNERS GP, L.L.C., PERCEPTIVE ADVISORS LLC, FRANKLIN RESOURCES INC, TCG Crossover Management, LLC, MILLENNIUM MANAGEMENT LLC, and BlackRock Inc..
This page lists
138
institutional shareholders reporting positions in this security
for the Q1 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.